_version_ 1783433122481700864
author Ali, Natasha
author_facet Ali, Natasha
author_sort Ali, Natasha
collection PubMed
description
format Online
Article
Text
id pubmed-6614098
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-66140982019-07-15 Chimeric antigen T cell receptor treatment in hematological malignancies Ali, Natasha Blood Res Perspective Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019-06 2019-06-25 /pmc/articles/PMC6614098/ /pubmed/31309082 http://dx.doi.org/10.5045/br.2019.54.2.81 Text en © 2019 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspective
Ali, Natasha
Chimeric antigen T cell receptor treatment in hematological malignancies
title Chimeric antigen T cell receptor treatment in hematological malignancies
title_full Chimeric antigen T cell receptor treatment in hematological malignancies
title_fullStr Chimeric antigen T cell receptor treatment in hematological malignancies
title_full_unstemmed Chimeric antigen T cell receptor treatment in hematological malignancies
title_short Chimeric antigen T cell receptor treatment in hematological malignancies
title_sort chimeric antigen t cell receptor treatment in hematological malignancies
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614098/
https://www.ncbi.nlm.nih.gov/pubmed/31309082
http://dx.doi.org/10.5045/br.2019.54.2.81
work_keys_str_mv AT alinatasha chimericantigentcellreceptortreatmentinhematologicalmalignancies
AT chimericantigentcellreceptortreatmentinhematologicalmalignancies